Details for Patent: 6,166,197
✉ Email this page to a colleague
Summary for Patent: 6,166,197
Title: | Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions |
Abstract: | Oligonucleotide analogs are disclosed having pyrimidine monomeric sub-units therein that are modified at the 2' and 5 positions. Monomeric sub-units having these modifications may be further modified at the 2 position. |
Inventor(s): | Cook; Phillip Dan (San Marcos, CA), Sanghvi; Yogesh S. (San Marcos, CA), Sprankle; Kelly G. (Vista, CA), Ross; Bruce S. (Carlsbad, CA), Griffey; Rich H. (Vista, CA) |
Assignee: | ISIS Pharmaceuticals, Inc. (Carlsbad, CA) |
Application Number: | 08/398,901 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 6,166,197
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,166,197
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 327244 | ⤷ Sign Up | |||
Australia | 5359496 | ⤷ Sign Up | |||
Canada | 2214535 | ⤷ Sign Up | |||
Germany | 69636160 | ⤷ Sign Up | |||
European Patent Office | 0813539 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |